Researchers from the National University of Singapore (NUS) have made a groundbreaking discovery that could potentially revolutionize fertility treatments for older women. A team from the Mechanobiology Institute (MBI) and the NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality (ACRLE) has developed an innovative technique to enhance the reproductive potential of aged oocytes, or immature egg cells. The study, published in…
Axena Health, a medical device company specializing in female pelvic health, has announced that its Leva Pelvic Health System will be included in a significant clinical study funded by the National Institutes of Health’s (NIH) Pelvic Floor Disorders Network (PFDN). The study, titled “Training for Urinary Leakage Improvement after Pregnancy” (TULIP), aims to compare three first-line treatments for postpartum urinary incontinence (UI).…
YourChoice Therapeutics, a San Francisco-based biopharmaceutical company, has announced the commencement of its second human study for YCT-529, a hormone-free male birth control pill. The company has dosed its first cohort of male volunteers in a phase 1b/2a clinical study, following the successful completion of a phase 1a study that demonstrated the drug candidate’s safety for use in men. The phase 1b/2a…
University of Iowa Health Care and UK-based Naitive Technologies have initiated a joint project to evaluate the diagnostic accuracy of OsteoSight, an FDA-designated breakthrough medical device. This device is designed to identify individuals at risk of low bone mineral density (BMD) using X-rays taken for other medical purposes. The project aims to enhance the early detection of osteoporosis, a condition affecting millions…
Paxman has announced the publication of the largest real-world study on scalp cooling to date. The study, known as the Dutch Scalp Cooling Registry, spans 13 years and includes data from 7,424 patients across 68 hospitals in the Netherlands. The findings, published in The Oncologist, provide crucial insights into mitigating chemotherapy-induced alopecia (CIA) and solidifying the understanding of factors that contribute to…
DeepLook Medical, the company behind DL Precise, the first FDA-cleared AI technology designed to detect cancer in dense breast tissue, has announced the successful first close of its Series A funding round. The round was led by Xcellerant Ventures, with additional support from OKG Capital. This funding milestone will support the company’s continued growth and its efforts to enhance cancer detection and…
Foria, a natural wellness brand specializing in intimate health, has announced results from a new study published in Nature Partner Journal: Women’s Health. The research suggests that Foria’s Relief Melts, vaginal suppositories containing high levels of cannabidiol (CBD), may effectively alleviate menstrual pain and related symptoms. The study, conducted by researchers at McLean Hospital, followed 77 women who used Foria’s Relief Melts…
New research from neurotech company Parasym has revealed that targeting the vagus nerve through neuromodulation can significantly reduce symptoms of endometriosis, a condition affecting 1 in 10 women in the UK. Parasym’s wearable device, Nurosym, has shown a 78% reduction in inflammation and a 50% increase in heart rate variability (HRV), which are key factors in managing endometriosis. Endometriosis occurs when tissue…
